
LeMaitre Vascular (LMAT) Stock Forecast & Price Target
LeMaitre Vascular (LMAT) Analyst Ratings
Bulls say
LeMaitre Vascular is well-positioned for growth in the medical device industry due to its strong financials, strategic focus on niche products, and potential for expansion through mergers and acquisitions. With consistent double-digit revenue growth and ambitious targets set by management for sales and international revenue, the company is poised to continue its success. However, it must be mindful of potential risks related to compliance and disruptions in its manufacturing and tissue processing services.
Bears say
LeMaitre Vascular is experiencing strong top-line growth driven by grafts, valvulotomes, and carotid shunts, with the EMEA region leading geographically. However, their balance sheet shows a high level of debt and their free cash flow has decreased from the previous year. While the company has filed a claim with the FDA to expand cannulation labeling, this may not have a significant impact on their financials.
This aggregate rating is based on analysts' research of LeMaitre Vascular and is not a guaranteed prediction by Public.com or investment advice.
LeMaitre Vascular (LMAT) Analyst Forecast & Price Prediction
Start investing in LeMaitre Vascular (LMAT)
Order type
Buy in
Order amount
Est. shares
0 shares